# EDGAR Filing Document

**Accession Number:** 0001974915
**File Stem:** 0001974915-26-000004
**Filing Date:** 2026-5
**Character Count:** 12947
**Document Hash:** e845696183c6d7bde195dee12cf536f3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001974915-26-000004.hdr.sgml**: 20260515

**ACCESSION NUMBER**: 0001974915-26-000004

**CONFORMED SUBMISSION TYPE**: 13F-HR

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260515

**DATE AS OF CHANGE**: 20260515

**EFFECTIVENESS DATE**: 20260515

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Vestal Point Capital, LP
- **CENTRAL INDEX KEY:** 0001974915

**ORGANIZATION NAME:**
- **EIN:** 922296021
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 13F-HR
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-23784
- **FILM NUMBER:** 26987192

**BUSINESS ADDRESS:**
- **STREET 1:** 632 BROADWAY
- **STREET 2:** SUITE 602
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10012
- **BUSINESS PHONE:** 6469894000

**MAIL ADDRESS:**
- **STREET 1:** 632 BROADWAY
- **STREET 2:** SUITE 602
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10012

### FORM 13F COVER PAGE

**Report for the Calendar Year or Quarter Ended:** 03-31-2026

**Check here if Amendment** [ ] **Amendment Number:** 

**This Amendment (Check only one.):** [ ] is a restatement.

[ ] adds new holdings entries.

**Institutional Investment Manager Filing this Report:**

**Name:** Vestal Point Capital LP<br>**Address:** 632 BROADWAY<br>SUITE 602<br>NEW YORK, NY 10012

**Form 13F File Number:** 028-23784

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

**Person Signing this Report on Behalf of Reporting Manager:**

**Name:** Ilko Menkov<br>**Title:** Partner COO and CCO<br>**Phone:** 6469894002

**Signature, Place, and Date of Signing:**

Ilko Menkov  New York, NY  05-15-2026<br>[Signature]  [City, State]  [Date]

**Report Type (Check only one.):**

[x] **13F HOLDINGS REPORT.** (Check here if all holdings of this reporting manager are reported in this report.)

[ ] **13F NOTICE.** (Check here if no holdings are reported in this report, and all holdings are reported by other reporting manager(s).)

[ ] **13F COMBINATION REPORT.** (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)

### Form 13F Summary Page

**Report Summary:**

**Number of Other Included Managers:** 0

**Form 13F Information Table Entry Total:** 90

**Form 13F Information Table Value Total:** $3576817318

      (round to nearest dollar)

**List of Other Included Managers:**

Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.

[If there are no entries in this list, state “NONE” and omit the column headings and list entries.]

**NONE**

### FORM 13F INFORMATION TABLE

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | VALUE (x$1000) | SHRS OR PRN AMT | SH/PRN | PUT/CALL | INVESTMENT DISCRETION | OTHER MANAGER | VOTING AUTHORITY | VOTING AUTHORITY | VOTING AUTHORITY |
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | VALUE (x$1000) | SHRS OR PRN AMT | SH/PRN | PUT/CALL | INVESTMENT DISCRETION | OTHER MANAGER | SOLE | SHARED | NONE |
| Abivax SA | SPONSORED ADS | 00370M103 |  | 167025000 | 1500000 | SH |  | SOLE |  | 1500000 | 0 | 0 |
| Absci Corp | COM | 00091E109 |  | 696657 | 232219 | SH |  | SOLE |  | 232219 | 0 | 0 |
| Agios Pharmaceuticals Inc | COM | 00847X104 |  | 15223500 | 450000 | SH |  | SOLE |  | 450000 | 0 | 0 |
| Alcon AG | ORD SHS | H01301128 |  | 60280000 | 800000 | SH |  | SOLE |  | 800000 | 0 | 0 |
| Alto Neuroscience Inc | COM SHS | 02157Q109 |  | 46400406 | 2064075 | SH |  | SOLE |  | 2064075 | 0 | 0 |
| Anteris Technologies Global Co | COM | 03675P102 |  | 6353529 | 1144780 | SH |  | SOLE |  | 1144780 | 0 | 0 |
| Apogee Therapeutics Inc | COM | 03770N101 |  | 92587000 | 1100000 | SH |  | SOLE |  | 1100000 | 0 | 0 |
| Aprea Therapeutics Inc | COM NEW | 03836J201 |  | 267015 | 350000 | SH |  | SOLE |  | 350000 | 0 | 0 |
| Arrowhead Pharmaceuticals Inc | COM | 04280A100 |  | 142642500 | 2275000 | SH |  | SOLE |  | 2275000 | 0 | 0 |
| Arvinas Inc | COM | 04335A105 |  | 9597929 | 905465 | SH |  | SOLE |  | 905465 | 0 | 0 |
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 |  | 85773750 | 375000 | SH |  | SOLE |  | 375000 | 0 | 0 |
| AstraZeneca PLC | ORD | G0593M107 |  | 19722000 | 100000 | SH |  | SOLE |  | 100000 | 0 | 0 |
| Beta Bionics Inc | COM | 08659B102 |  | 22159410 | 2211518 | SH |  | SOLE |  | 2211518 | 0 | 0 |
| Bicara Therapeutics Inc | COM | 055477103 |  | 107903250 | 5425000 | SH |  | SOLE |  | 5425000 | 0 | 0 |
| BioCryst Pharmaceuticals Inc | COM | 09058V103 |  | 66878000 | 7025000 | SH |  | SOLE |  | 7025000 | 0 | 0 |
| BioMarin Pharmaceutical Inc | COM | 09061G101 |  | 201951750 | 3575000 | SH |  | SOLE |  | 3575000 | 0 | 0 |
| Boston Scientific Corp | COM | 101137107 |  | 50200000 | 800000 | SH |  | SOLE |  | 800000 | 0 | 0 |
| Bright Minds Biosciences Inc | COM NEW | 10919W405 |  | 35924517 | 492319 | SH |  | SOLE |  | 492319 | 0 | 0 |
| Bristol-Myers Squibb Co | COM | 110122108 |  | 60650000 | 1000000 | SH |  | SOLE |  | 1000000 | 0 | 0 |
| Candel Therapeutics Inc | COM | 137404109 |  | 5512500 | 1125000 | SH |  | SOLE |  | 1125000 | 0 | 0 |
| Celldex Therapeutics Inc | COM NEW | 15117B202 |  | 38830514 | 1224165 | SH |  | SOLE |  | 1224165 | 0 | 0 |
| Cogent Biosciences Inc | COM | 19240Q201 |  | 47376879 | 1230888 | SH |  | SOLE |  | 1230888 | 0 | 0 |
| Crescent Biopharma Inc | COM | G2545C104 |  | 27555000 | 1500000 | SH |  | SOLE |  | 1500000 | 0 | 0 |
| Cytokinetics Inc | COM NEW | 23282W605 |  | 19773000 | 300000 | SH |  | SOLE |  | 300000 | 0 | 0 |
| Damora Therapeutics Inc | COM NEW | 36322Q206 |  | 15540000 | 600000 | SH |  | SOLE |  | 600000 | 0 | 0 |
| Denali Therapeutics Inc | COM | 24823R105 |  | 34047859 | 1773326 | SH |  | SOLE |  | 1773326 | 0 | 0 |
| Disc Medicine Inc | COM | 254604101 |  | 44758000 | 700000 | SH |  | SOLE |  | 700000 | 0 | 0 |
| Dyne Therapeutics Inc | COM | 26818M108 |  | 72520000 | 4000000 | SH |  | SOLE |  | 4000000 | 0 | 0 |
| enGene Therapeutics Inc | COM | 29286M105 |  | 14743650 | 2165000 | SH |  | SOLE |  | 2165000 | 0 | 0 |
| Enliven Therapeutics Inc | COM | 29337E102 |  | 127400000 | 3250000 | SH |  | SOLE |  | 3250000 | 0 | 0 |
| Fulcrum Therapeutics Inc | COM | 359616109 |  | 8437000 | 1100000 | SH |  | SOLE |  | 1100000 | 0 | 0 |
| GE HealthCare Technologies Inc | COMMON STOCK | 36266G107 |  | 17795000 | 250000 | SH |  | SOLE |  | 250000 | 0 | 0 |
| GeneDx Holdings Corp | COM CL A | 81663L200 |  | 16055000 | 250000 | SH |  | SOLE |  | 250000 | 0 | 0 |
| Geron Corp | COM | 374163103 |  | 3784600 | 2540000 | SH |  | SOLE |  | 2540000 | 0 | 0 |
| Globus Medical Inc | CL A | 379577208 |  | 52602403 | 610520 | SH |  | SOLE |  | 610520 | 0 | 0 |
| Immatics NV | SHS | N44445109 |  | 60762000 | 6175000 | SH |  | SOLE |  | 6175000 | 0 | 0 |
| Immunocore Holdings PLC | ADS | 45258D105 |  | 83421070 | 2766868 | SH |  | SOLE |  | 2766868 | 0 | 0 |
| Inspire Medical Systems Inc | COM | 457730109 |  | 27815495 | 539269 | SH |  | SOLE |  | 539269 | 0 | 0 |
| Insulet Corp | COM | 45784P101 |  | 10618114 | 50601 | SH |  | SOLE |  | 50601 | 0 | 0 |
| KalVista Pharmaceuticals Inc | COM | 483497103 |  | 37240500 | 1850000 | SH |  | SOLE |  | 1850000 | 0 | 0 |
| Lexeo Therapeutics Inc | COM | 52886X107 |  | 25686500 | 4475000 | SH |  | SOLE |  | 4475000 | 0 | 0 |
| MacroGenics Inc | COM | 556099109 |  | 809200 | 280000 | SH |  | SOLE |  | 280000 | 0 | 0 |
| Madrigal Pharmaceuticals Inc | COM | 558868105 |  | 16472554 | 31468 | SH |  | SOLE |  | 31468 | 0 | 0 |
| MapLight Therapeutics Inc | COM | 56565P103 |  | 8538600 | 420000 | SH |  | SOLE |  | 420000 | 0 | 0 |
| Monopar Therapeutics Inc | COM NEW | 61023L207 |  | 3584252 | 65418 | SH |  | SOLE |  | 65418 | 0 | 0 |
| Monte Rosa Therapeutics Inc | COM | 61225M102 |  | 59276999 | 3603465 | SH |  | SOLE |  | 3603465 | 0 | 0 |
| Myriad Genetics Inc | COM | 62855J104 |  | 7416000 | 1648000 | SH |  | SOLE |  | 1648000 | 0 | 0 |
| Nektar Therapeutics | COM NEW | 640268306 |  | 20505750 | 285000 | SH |  | SOLE |  | 285000 | 0 | 0 |
| Neurocrine Biosciences Inc | COM | 64125C109 |  | 164675000 | 1250000 | SH |  | SOLE |  | 1250000 | 0 | 0 |
| Novocure Ltd | ORD SHS | G6674U108 |  | 2725000 | 250000 | SH |  | SOLE |  | 250000 | 0 | 0 |
| Nurix Therapeutics Inc | COM | 67080M103 |  | 100750000 | 6500000 | SH |  | SOLE |  | 6500000 | 0 | 0 |
| Nuvalent Inc | COM | 670703107 |  | 49351702 | 481715 | SH |  | SOLE |  | 481715 | 0 | 0 |
| Nyxoah SA | SHS | B6S7WD106 |  | 2536490 | 868661 | SH |  | SOLE |  | 868661 | 0 | 0 |
| Olema Pharmaceuticals Inc | COM | 68062P106 |  | 6389695 | 428551 | SH |  | SOLE |  | 428551 | 0 | 0 |
| OnKure Therapeutics Inc | COM CL A | 68277Q105 |  | 7616851 | 1839819 | SH |  | SOLE |  | 1839819 | 0 | 0 |
| Palisade Bio Inc | COM | 696389402 |  | 4375000 | 2500000 | SH |  | SOLE |  | 2500000 | 0 | 0 |
| Passage Bio Inc | COM NEW | 702712209 |  | 2394250 | 305000 | SH |  | SOLE |  | 305000 | 0 | 0 |
| Protagonist Therapeutics Inc | COM | 74366E102 |  | 34377159 | 326159 | SH |  | SOLE |  | 326159 | 0 | 0 |
| Rapport Therapeutics Inc | COM | 75383L102 |  | 44939605 | 1436229 | SH |  | SOLE |  | 1436229 | 0 | 0 |
| Regeneron Pharmaceuticals Inc | COM | 75886F107 |  | 30905600 | 40000 | SH |  | SOLE |  | 40000 | 0 | 0 |
| REGENXBIO Inc | COM | 75901B107 |  | 909440 | 108525 | SH |  | SOLE |  | 108525 | 0 | 0 |
| Repligen Corp | COM | 759916109 |  | 108983500 | 925000 | SH |  | SOLE |  | 925000 | 0 | 0 |
| Revolution Medicines Inc | COM | 76155X100 |  | 230968750 | 2375000 | SH |  | SOLE |  | 2375000 | 0 | 0 |
| Sanofi SA | SPONSORED ADR | 80105N105 |  | 67452000 | 1400000 | SH |  | SOLE |  | 1400000 | 0 | 0 |
| Savara Inc | COM | 805111101 |  | 14196284 | 2600052 | SH |  | SOLE |  | 2600052 | 0 | 0 |
| Scholar Rock Holding Corp | COM | 80706P103 |  | 65108586 | 1324422 | SH |  | SOLE |  | 1324422 | 0 | 0 |
| Soleno Therapeutics Inc | COM | 834203309 |  | 24440400 | 730000 | SH |  | SOLE |  | 730000 | 0 | 0 |
| Solid Biosciences Inc | COM NEW | 83422E204 |  | 36000000 | 5000000 | SH |  | SOLE |  | 5000000 | 0 | 0 |
| SpyGlass Pharma Inc | COM SHS | 85220G109 |  | 17275752 | 666760 | SH |  | SOLE |  | 666760 | 0 | 0 |
| Surrozen Inc | COM NEW | 86889P208 |  | 9863738 | 338611 | SH |  | SOLE |  | 338611 | 0 | 0 |
| Tarsus Pharmaceuticals Inc | COM | 87650L103 |  | 14030000 | 200000 | SH |  | SOLE |  | 200000 | 0 | 0 |
| Taysha Gene Therapies Inc | COM SHS | 877619106 |  | 80460000 | 18000000 | SH |  | SOLE |  | 18000000 | 0 | 0 |
| Tectonic Therapeutic Inc | COM | 878972108 |  | 10138480 | 328000 | SH |  | SOLE |  | 328000 | 0 | 0 |
| Tenax Therapeutics Inc | COM NEW | 88032L605 |  | 854490 | 53439 | SH |  | SOLE |  | 53439 | 0 | 0 |
| Terns Pharmaceuticals Inc | COM | 880881107 |  | 52720000 | 1000000 | SH |  | SOLE |  | 1000000 | 0 | 0 |
| Trevi Therapeutics Inc | COM | 89532M101 |  | 25846393 | 2166504 | SH |  | SOLE |  | 2166504 | 0 | 0 |
| Tyra Biosciences Inc | COM | 90240B106 |  | 2068200 | 54000 | SH |  | SOLE |  | 54000 | 0 | 0 |
| uniQure NV | SHS | N90064101 |  | 5869585 | 358996 | SH |  | SOLE |  | 358996 | 0 | 0 |
| United Therapeutics Corp | COM | 91307C102 |  | 44473500 | 75000 | SH |  | SOLE |  | 75000 | 0 | 0 |
| UroGen Pharma Ltd | COM | M96088105 |  | 2500640 | 139079 | SH |  | SOLE |  | 139079 | 0 | 0 |
| Vera Therapeutics Inc | CL A | 92337R101 |  | 55041037 | 1368159 | SH |  | SOLE |  | 1368159 | 0 | 0 |
| Veracyte Inc | COM | 92337F107 |  | 4209428 | 130687 | SH |  | SOLE |  | 130687 | 0 | 0 |
| Viking Therapeutics Inc | COM | 92686J106 |  | 29746343 | 914147 | SH |  | SOLE |  | 914147 | 0 | 0 |
| Voyager Therapeutics Inc | COM | 92915B106 |  | 11591333 | 3002936 | SH |  | SOLE |  | 3002936 | 0 | 0 |
| Waters Corp | COM | 941848103 |  | 29780000 | 100000 | SH |  | SOLE |  | 100000 | 0 | 0 |
| West Pharmaceutical Services I | COM | 955306105 |  | 18798000 | 75000 | SH |  | SOLE |  | 75000 | 0 | 0 |
| Xenon Pharmaceuticals Inc | COM | 98420N105 |  | 37210185 | 639900 | SH |  | SOLE |  | 639900 | 0 | 0 |
| Zenas Biopharma Inc | COM | 98937L105 |  | 3910000 | 200000 | SH |  | SOLE |  | 200000 | 0 | 0 |
| Zimmer Biomet Holdings Inc | COM | 98956P102 |  | 17179800 | 190000 | SH |  | SOLE |  | 190000 | 0 | 0 |
| Zura Bio Ltd | CLASS A ORD SHS | G9TY5A101 |  | 3040450 | 511000 | SH |  | SOLE |  | 511000 | 0 | 0 |

---